Hiroaki Masuzaki, Hirotaka Nagashima, Tomotaka Shingaki, Tomonori Oura, Ichiro Tatsuno. Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study. Diabetes, Obesity and Metabolism. 2026
Koutaro Yokote, Yasushi Fukushima, Tomotaka Shingaki, Tomonori Oura, Wataru Ogawa. Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT-J trial. Diabetes, Obesity and Metabolism. 2026
Masato Yoneda, Masakazu Takeuchi, Tomonori Oura, Atsushi Nakajima. Decreased fatty liver index with tirzepatide treatment in Japanese patients with type 2 diabetes: A SURPASS J-mono post hoc analysis. Diabetes, Obesity and Metabolism. 2026
Hanaka Mimura, Tomonori Oura, Rina Chin, Tetsuaki Hirase, Dai Shimono. Association Between Early Weight Loss and Metabolic Outcomes with Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J Post Hoc Analysis. Diabetes Therapy. 2025
Toshimasa Yamauchi, Taro Asakura, Tomotaka Shingaki, Tomonori Oura, Hideki Katagiri. Efficacy and safety of once-weekly tirzepatide in Japanese participants with type 2 diabetes who have obesity or overweight: Subpopulation analysis of the SURMOUNT-2 trial. Diabetes, Obesity and Metabolism. 2025